Add links

Anteris Technologies Limited
Formerly
  • Allied Healthcare Group (2011–2013)
  • Admedus (2013–2020)
Company typePublic
ASX: AVR
IndustryBiotechnology
Headquarters
Toowong
,
Australia
Websiteanteristech.com

Anteris Technologies Limited is an Australian biotechnology company.

History

Anteris originates from the merger of Allied Medical and BioMD. Allied Medical was a company spun out of mining company Fortescue Metals Group in 2005 which focused on selling medical equipment such as catheters.[1] It entered the biotechnology space in July 2010 when it purchased a 38.6 per cent stake in Brisbane-based Coridon for A$3 million.[2] By February 2011, its stake increased to 55 per cent.[3] In February 2011, Allied Medical agreed to a reverse takeover deal with BioMD, a listed biotech company.[3] The takeover was completed in June 2011 resulting in the combined company, Allied Healthcare Group, listing on the Australian Securities Exchange (ASX).[4][5][6]

In September 2012, Allied raised $10.4 million to launch CardioCel across Europe.[7] In November 2013, Allied Healthcare changed its name to Admedus.[8] In December 2013, Admedus purchased a manufacturing site in Malaga to scale-up production of CardioCel and support the development and manufacture of additional regenerative tissue products.[7]

In October 2019, Admedus sold its CardioCel and VascuCel patch business to U.S.-based LeMaitre Vascular.[9] Under the agreement, Admedus received A$22.8 million upfront followed by deferred payments of $1 million each at 12 months and at 36 months. Additionally, the company could receive up to $11.4 million in earn-out payments.[10] Admedus retained the right to manufacture CardioCel and VascuCel products at its Malaga facility for LeMaitre over the following three years.[9] In May 2020, Admedus changed its name to Anteris Technologies.[11]

References

  1. ^ Thomson, James (18 July 2010). "Medical company backed by mining billionaire Andrew Forrest launches biotech investment push". SmartCompany. Retrieved 14 March 2023.
  2. ^ Greenblat, Eli (18 July 2010). "Mining magnate invests in biotech". The Sydney Morning Herald. Retrieved 15 March 2023.
  3. ^ a b Evans, Nick (15 February 2011). "Forrest biotech company to list". PerthNow. Retrieved 15 March 2023.
  4. ^ Evans, Nick (31 May 2011). "BioMD's Allied takeover wrapping up soon". PerthNow. Retrieved 15 March 2023.
  5. ^ Stafford, Patrick (20 June 2011). "Andrew Forrest-backed biotech lists on ASX". SmartCompany. Archived from the original on 24 June 2011. Retrieved 15 March 2023.
  6. ^ "bioMD Limited Makes Offer for Unlisted Allied Medical to Create Diversified Healthcare Group" (Press release). BioSpace. 15 February 2011. Retrieved 16 March 2023.
  7. ^ a b Drummond, Cameron (12 December 2013). "Biotech company buys manufacturing facility". Business News. Retrieved 15 March 2023.
  8. ^ Smith, Sean (21 November 2013). "Allied rebrands as Admedus". The West Australian. Retrieved 15 March 2023.
  9. ^ a b "Admedus sells its CardioCel and VascuCel patch business for $A36.2m". Australian Manufacturing. 16 October 2019. Retrieved 15 March 2023.
  10. ^ Ford, Omar (14 October 2019). "Admedus Turns Attention to TAVR Program". mddionline.com. Retrieved 15 March 2023.
  11. ^ "Admedus Changes Name to Anteris Technologies Ltd" (Press release). GlobalNewswire. 1 June 2020. Retrieved 16 March 2023.

External links

source: http://en.wikipedia.org/wiki/Anteris_Technologies